P2.03b-077 EGFR/ALK+ Patient-Derived Xenografts from Advanced NSCLC for TKI Drug Selection & Resistance Development: The REAL-PDX Study

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
• 作者

  Michael Cabanero; Nhu-An Pham; Erin Stewart; Devalben Patel; Judy Mcconnell; Alexandria Grindlay; Frances Allison; Yuhui Wang; Ming Li; Frances Shepherd; Ming Tsao; Kazuhiro Yasufuku; Geoffrey Liu;

  展开▼
• 作者单位

  Departments of Laboratory Medicine and Pathobiology University of Toronto University Health;

  Princess Margaret Cancer Centre;

  Princess Margaret Cancer Centre;

  Dept of Medical Oncology and Haematology Princess Margaret Cancer Centre;

  Princess Margaret Cancer Centre;

  Princess Margaret Cancer Centre;

  Princess Margaret Cancer Centre;

  Princess Margaret Cancer Centre;

  Princess Margaret Cancer Centre;

  Dept of Medical Oncology and Haematology University of Toronto University Health Network;

  Departments of Laboratory Medicine and Pathobiology University of Toronto University Health;

  Division of Thoracic Surgery Toronto General Hospital University of Toronto University Health;

  Dept of Medical Oncology and Haematology University of Toronto University Health Network;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词